Arctic Bioscience AS (OSL:ABS)
Norway
· Delayed Price · Currency is NOK 3.870
+0.170 (4.59%)
At close: Dec 5, 2025
Arctic Bioscience AS Cash Flow Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Net Income | -43.36 | -47.93 | -45.51 | -34.02 | -42.58 | -22.59 | Upgrade
|
| Depreciation & Amortization | 1.75 | 2.89 | 5.38 | 3.73 | 2.52 | 1.19 | Upgrade
|
| Other Amortization | 3.39 | 2.26 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.02 | -0.01 | - | - | - | - | Upgrade
|
| Other Operating Activities | - | - | - | -0 | - | -0 | Upgrade
|
| Change in Accounts Receivable | 0.85 | -5 | 3.91 | -5.77 | 3.3 | 0.7 | Upgrade
|
| Change in Inventory | -1.94 | 3.81 | 2.67 | -6.94 | -2.28 | -8.78 | Upgrade
|
| Change in Accounts Payable | -5.11 | -0.78 | 2.82 | 9.89 | -1.57 | 3.46 | Upgrade
|
| Change in Other Net Operating Assets | 3.17 | -0.58 | 0.37 | 7.71 | 1.12 | 4.13 | Upgrade
|
| Operating Cash Flow | -41.27 | -45.36 | -30.37 | -25.4 | -39.49 | -21.89 | Upgrade
|
| Capital Expenditures | -17.16 | -50.81 | -34.7 | -58.57 | -36.5 | -13.43 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.23 | 0.18 | 2.23 | - | - | - | Upgrade
|
| Investing Cash Flow | -32.53 | -50.63 | -32.47 | -58.57 | -36.5 | -13.43 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 1.88 | Upgrade
|
| Long-Term Debt Issued | - | 20.24 | - | - | - | - | Upgrade
|
| Total Debt Issued | 57.06 | 20.24 | - | - | - | 1.88 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -1.88 | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.58 | -2.2 | - | -6.58 | -0.58 | Upgrade
|
| Total Debt Repaid | -0.6 | -0.58 | -2.2 | - | -8.45 | -0.58 | Upgrade
|
| Net Debt Issued (Repaid) | 56.46 | 19.66 | -2.2 | - | -8.45 | 1.3 | Upgrade
|
| Issuance of Common Stock | - | - | 0.49 | 0.75 | 299.21 | 22.63 | Upgrade
|
| Financing Cash Flow | 56.46 | 19.66 | -1.71 | 0.75 | 290.76 | 23.93 | Upgrade
|
| Net Cash Flow | -17.34 | -76.32 | -64.55 | -83.21 | 214.76 | -11.39 | Upgrade
|
| Free Cash Flow | -58.42 | -96.17 | -65.07 | -83.96 | -76 | -35.32 | Upgrade
|
| Free Cash Flow Margin | -127.29% | -216.58% | -192.78% | -243.58% | -353.22% | -171.52% | Upgrade
|
| Free Cash Flow Per Share | -2.24 | -3.79 | -2.56 | -3.43 | -3.12 | -2.54 | Upgrade
|
| Levered Free Cash Flow | -34.85 | -70.9 | -60.46 | -71.64 | -58.59 | -26.02 | Upgrade
|
| Unlevered Free Cash Flow | -31.23 | -68.93 | -59.84 | -71.64 | -58.38 | -25.7 | Upgrade
|
| Change in Working Capital | -3.03 | -2.56 | 9.76 | 4.9 | 0.57 | -0.49 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.